CNXU
Conexeu Sciences Inc. • NASDAQ
$11.18 ▲ 17.68% (+1.68)
CNXU
Conexeu Sciences Inc.NASDAQ • $11.18 ▲ 17.68% (+1.68)
Market Cap $235.78 M
52w High $18.79
52w Low $8.14
P/E -55.90
Volume 339.77K
Outstanding Shares 20.92M
Market Cap $235.78 M
52w High $18.79
52w Low $8.14
P/E -55.90
Volume 339.77K
Outstanding Shares 20.92M
About Conexeu Sciences Inc.
www.conexeu.comConexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
CEO
Miles Harrison
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public May 21, 2026
Method of going public Direct Listing
Full time employees 4
SEP
30 WED
Upcoming Earnings
Date Sep 30, 2026
Day Wednesday
Revenue Est. —
Price Target
Target High $20
Target Low $20
Target Median $20
Target Consensus $20